Stephen Camarata is professor of hearing and speech sciences and of psychiatry at Vanderbilt University in Nashville, Tennessee. His expertise includes assessment and treatment of communication skills in children with autism and other developmental differences. He has published more than 100 papers on this topic and is the author of “Late Talking Children: A Symptom or a Stage” and writes for Psychology Today.
Stephen Camarata
Professor
Vanderbilt University
From this contributor
How to define verbal ability in autistic children
Researchers use a variety of measures and definitions to characterize autistic children who speak few or no words.
How to define verbal ability in autistic children
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.